Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy

被引:37
作者
Prendergast, Andrew [1 ]
Bwakura-Dangarembizi, Mutsa F. [2 ]
Cook, Adrian D. [1 ]
Bakeera-Kitaka, Sabrina [3 ]
Natukunda, Eva [4 ]
Ntege, Patricia Nahirya [5 ]
Nathoo, Kusum J. [2 ]
Karungi, Christine [4 ]
Lutaakome, Joseph [5 ]
Kekitiinwa, Adeodata [3 ]
Gibb, Diana M. [1 ]
机构
[1] MRC Clin Trials Unit, London NW1 2DA, England
[2] Univ Zimbabwe, Harare, Zimbabwe
[3] Mulago Hosp, Baylor Uganda Paediat Infect Dis Ctr, Kampala, Uganda
[4] Joint Clin Res Ctr, Kampala, Uganda
[5] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda
基金
英国医学研究理事会;
关键词
children; HIV; kwashiorkor; malnutrition; marasmus; mortality; ZAMBIAN CHILDREN; MORTALITY;
D O I
10.1097/QAD.0b013e328345e56b
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To describe early hospitalization for severe malnutrition in HIV-infected children initiating antiretroviral therapy (ART). Design: Randomized trial of induction-maintenance and monitoring strategies in HIV-infected children. Setting: Three tertiary hospitals in Uganda and one in Zimbabwe. Participants: 1207 HIV-infected children, median age 6 years (range, 3 months to 17 years). Intervention: Abacavir, lamivudine and nevirapine or efavirenz were given; children in induction-maintenance arms also received zidovudine to week 36. Pre-ART inpatient/outpatient nutritional rehabilitation for children with baseline severe malnutrition. Main outcome measures: Hospitalization for severe malnutrition and change in CD4 cell percentage by week 12 after ART. Mortality and change in weight-for-age Z-score (WAZ) by week 24 after ART. Results: Thirty-nine of 1207 (3.2%) children were hospitalized for severe malnutrition (20 with oedema), median 28 days [interquartile range (IQR) 14, 36] after ART for marasmus and 26 days (IQR 14, 56) after ART for kwashiorkor. Hospitalized children had lower baseline and greater 24-week rise in WAZ than nonhospitalized children (P < 0.001). Twenty-nine of 39 (74%) children admitted for severe malnutrition had underlying infections. Of 220 children with advanced disease (baseline WAZ and CD4 cell Z-scores both < - 3), 7.3% [95% confidence interval (CI) 3.8, 10.7] developed kwashiorkor and 3.6% (95% CI 1.2, 6.1) developed marasmus by week 12. CD4 cell percentage rise was similar among groups (P = 0.37). Twenty-four-week mortality was 32, 20 and 1.7% among children hospitalized with marasmus, kwashiorkor and not hospitalized, respectively, (P < 0.001). Conclusion: One in nine children with advanced HIV required early hospitalization for severe malnutrition after ART, with a 15-fold increase in 6-month mortality compared with nonhospitalized children. Integration of HIV/malnutrition services and further research to determine optimal ART timing, role of supplementary feeding and antimicrobial prophylaxis are urgently required. (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:951 / 956
页数:6
相关论文
共 50 条
  • [21] First-line antiretroviral therapy for HIV-infected children
    Terris-Prestholt, Fern
    AIDS, 2015, 29 (10) : 1261 - 1262
  • [22] The association between oral disease and type of antiretroviral therapy among perinatally HIV-infected youth
    Shiboski, Caroline H.
    Yao, Tzy-Jyun
    Russell, Jonathan S.
    Ryder, Mark I.
    Van Dyke, Russell B.
    Seage, George R., III
    Moscicki, Anna-Barbara
    AIDS, 2018, 32 (17) : 2497 - 2505
  • [23] Antiretroviral drugs in HIV-infected children
    Vigano, Alessandra
    Manfredini, Valeria
    Penagini, Francesca
    Giacomet, Vania
    Zuccotti, Gian Vincenzo
    PHARMACOLOGICAL RESEARCH, 2011, 64 (01) : 1 - 3
  • [24] Malnutrition in HIV infected children on antiretroviral drugs in a cohort of Ghanaian children
    Intiful, Freda D.
    Abdulai, Hikmatu
    Nyarko, Ruth
    Tette, Edem
    Asante, Matilda
    HELIYON, 2021, 7 (12)
  • [25] The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy
    Paton, N. I.
    Sangeetha, S.
    Earnest, A.
    Bellamy, R.
    HIV MEDICINE, 2006, 7 (05) : 323 - 330
  • [26] Reasons for hospitalization in HIV-infected children in West Africa
    Dicko, Fatoumata
    Desmonde, Sophie
    Koumakpai, Sikiratou
    Dior-Mbodj, Helene
    Koueta, Fla
    Baeta, Novisi
    Kone, Niaboula
    Akakpo, Jocelyn
    Sy, Haby Signate
    Ye, Diarra
    Renner, Lorna
    Lewden, Charlotte
    Leroy, Valeriane
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17
  • [27] Early Mortality and Loss to Follow-up in HIV-Infected Children Starting Antiretroviral Therapy in Southern Africa
    Fenner, Lukas
    Brinkhof, Martin W. G.
    Keiser, Olivia
    Weigel, Ralf
    Cornell, Morna
    Moultrie, Harry
    Prozesky, Hans
    Technau, Karl
    Eley, Brian
    Vaz, Paula
    Pascoe, Margaret
    Giddy, Janet
    Van Cutsem, Gilles
    Wood, Robin
    Egger, Matthias
    Davies, Mary-Ann
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 54 (05) : 524 - 532
  • [28] Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam
    Do Duy Cuong
    Thorson, Anna
    Sonnerborg, Anders
    Nguyen Phuong Hoa
    Nguyen Thi Kim Chuc
    Ho Dang Phuc
    Larsson, Mattias
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 44 (03) : 201 - 208
  • [29] Safety and Tolerability of Antiretroviral Therapy Among HIV-Infected Children And Adolescents In UGANDA
    Tukei, Vincent J.
    Asiimwe, Alice
    Maganda, Albert
    Atugonza, Rita
    Sebuliba, Isaac
    Bakeera-Kitaka, Sabrina
    Musoke, Phillipa
    Kalyesubula, Israel
    Kekitiinwa, Adeodata
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (03) : 274 - 280
  • [30] When to initiate antiretroviral therapy in HIV-infected children?
    Thuret, I
    ARCHIVES DE PEDIATRIE, 2004, 11 (12): : 1521 - 1524